Back to Gastroenterology
Gastroenterologyv2016Evidence-Based

MELD Na (UNOS/OPTN)

Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016

Clinical Input Parameters

mg/dL
Range: 0.01 — 40 mg/dL
mg/dL
Range: 0.01 — 100 mg/dL
Range: 0.01 — 100
mEq/L
Range: 100 — 150 mEq/L
Clinical Assessment
Awaiting Parameters
meld na score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The MELD Na (UNOS/OPTN) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

MELD(i) = 0.957 × ln(Cr) + 0.378 × ln(bilirubin) + 1.120 × ln(INR) + 0.643, then if MELD(i) > 11: MELD Na = MELD(i) + 1.32 × (137 - Na) - [0.033 × MELD(i) × (137 - Na)]

Clinical Pearls & Practice Notes

  • Used by UNOS/OPTN for liver transplant allocation since January 2016
  • Sodium adjustment only applied if initial MELD > 11
  • For patients on dialysis ≥2 times in past week, creatinine value is set to 4.0
  • Laboratory values less than 1.0 are set to 1.0 for calculation
  • Sodium values are bounded between 125-137 mEq/L
  • Final score is rounded to nearest whole number and bounded between 6-40

Evidence & Literature Citations

  1. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.
  2. Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563.
  3. OPTN Policy 9: Allocation of Livers and Liver-Intestines. Organ Procurement and Transplantation Network. Effective January 11, 2016.

Score Interpretation Ranges

Low Risk6 – 9 pts

MELD Na ≤9

Moderate Risk10 – 19 pts

MELD Na 10-19

High Risk20 – 29 pts

MELD Na 20-29

Very High Risk30 – 39 pts

MELD Na 30-39

Extremely High Risk40 – 40 pts

MELD Na ≥40

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.